Ophthalmic panel tackles Prelex technique
This article was originally published in The Gray Sheet
Executive Summary
Study criteria for intraocular lenses to correct presbyopia following clear lens extraction will be explored March 5 by FDA's Ophthalmic Devices Panel in Gaithersburg, Md. Potential candidates for a presbyopic lens exchange (Prelex) indication include Advanced Medical Optics' Array multifocal lens, Eyeonics' CrystaLens AT-45 and Alcon's Acrysof multifocal IOL. Array has been available for U.S. use in cataract surgery since 1997, while AT-45 earned approval Nov. 14 for aphakic treatment of near, immediate and distance vision (1"The Gray Sheet" Dec. 22, 2003, p. 25)...
You may also be interested in...
CrystaLens Accommodating IOL First To Market; Firm Eyes Expanded Labeling
Eyeonics, Inc. will file a supplemental PMA for its CrystaLens AT-45 accommodating posterior chamber intraocular lens to broaden the treatment range beyond 1.0 diopter
Purespring Therapeutics: Pioneering Gene Therapy For Kidney Disorders
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Sandoz Pioneers Posaconazole And Silodosin In Canada
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: